DOP2002000519A - PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH - Google Patents
PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTHInfo
- Publication number
- DOP2002000519A DOP2002000519A DO2002000519A DO2002000519A DOP2002000519A DO P2002000519 A DOP2002000519 A DO P2002000519A DO 2002000519 A DO2002000519 A DO 2002000519A DO 2002000519 A DO2002000519 A DO 2002000519A DO P2002000519 A DOP2002000519 A DO P2002000519A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- treatment
- procedure
- preparation
- cellular growth
- abnormal cellular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a procedimientos para preparar compuestos de formula. Y a sales, pro fármacos y solvatos farmacéuticamente aceptables de los mismos, en la que R1, R3, R4, R5, R11, m y p son como se han definido en este documento. Los compuestos de formula 1 son útiles en el tratamiento del crecimiento celular anormal en mamíferos por la administración de composiciones farmacéuticas.The invention relates to processes for preparing compounds of formula. And pharmaceutically acceptable salts, pro drugs and solvates thereof, wherein R1, R3, R4, R5, R11, m and p are as defined herein. The compounds of formula 1 are useful in the treatment of abnormal cell growth in mammals by the administration of pharmaceutical compositions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33464701P | 2001-11-30 | 2001-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000519A true DOP2002000519A (en) | 2003-05-31 |
Family
ID=23308141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000519A DOP2002000519A (en) | 2001-11-30 | 2002-11-21 | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20030144506A1 (en) |
| EP (1) | EP1448551B1 (en) |
| JP (1) | JP4220388B2 (en) |
| KR (1) | KR20040054813A (en) |
| CN (1) | CN1639149A (en) |
| AR (1) | AR037591A1 (en) |
| AT (1) | ATE377009T1 (en) |
| AU (1) | AU2002337428A1 (en) |
| BR (1) | BR0214606A (en) |
| CA (1) | CA2462149C (en) |
| DE (1) | DE60223279T2 (en) |
| DO (1) | DOP2002000519A (en) |
| ES (1) | ES2295409T3 (en) |
| GT (1) | GT200200245A (en) |
| HN (1) | HN2002000334A (en) |
| HU (1) | HUP0500117A3 (en) |
| IL (1) | IL160971A0 (en) |
| MX (1) | MXPA04005157A (en) |
| PA (1) | PA8558601A1 (en) |
| PE (1) | PE20030643A1 (en) |
| PL (1) | PL370911A1 (en) |
| PY (1) | PY0229003A (en) |
| RS (1) | RS44004A (en) |
| RU (1) | RU2004116345A (en) |
| SV (1) | SV2004001419A (en) |
| TN (1) | TNSN02096A1 (en) |
| TW (1) | TW200300691A (en) |
| WO (1) | WO2003045939A1 (en) |
| ZA (1) | ZA200402054B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004054585A1 (en) * | 2002-12-18 | 2004-07-01 | Pfizer Products Inc. | 4-anilino quinazoline derivatives for the treatment of abnormal cell growth |
| JP2006512355A (en) * | 2002-12-19 | 2006-04-13 | ファイザー・プロダクツ・インク | E-2-methoxy-N- (3- {4- [3-methyl-4- (6-methylpyridin-3-yloxy) -phenylamino] -quinazolin-6-yl} -allyl) -acetamide complex , Their manufacturing method and use |
| RS20050652A (en) * | 2003-04-09 | 2007-11-15 | Pfizer Products Inc., | Process for the preparation of n- (((pyridinyloxy)- phenylamino)quinazolinyl)- alyl)acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
| NZ544472A (en) | 2003-07-03 | 2009-04-30 | Myriad Genetics Inc | Compounds and therapeutical use thereof |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| US20050192298A1 (en) * | 2004-02-27 | 2005-09-01 | Pfizer Inc | Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide |
| CN1972688B (en) * | 2004-05-06 | 2012-06-27 | 沃尼尔·朗伯有限责任公司 | 4-phenylamino-quinazolin-6-yl-amides |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| CA2635837A1 (en) * | 2005-12-02 | 2007-06-28 | The Paper Products Limited | Holographic flexible tube laminate for packaging and method of making the same |
| AU2019346550A1 (en) | 2018-09-25 | 2021-04-22 | Black Diamond Therapeutics, Inc. | Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use |
| EP4013749B1 (en) | 2019-08-15 | 2026-03-11 | Black Diamond Therapeutics, Inc. | Alkynyl quinazoline compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW321649B (en) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| DE19501481A1 (en) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,8-disubstituted quinazolinones |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| HRP20021005A2 (en) * | 2000-06-22 | 2004-02-29 | Pfizer Prod Inc | Substituted bicyclic derivatives for the treatment of abnormal cell growth |
-
2002
- 2002-10-03 HU HU0500117A patent/HUP0500117A3/en unknown
- 2002-10-03 WO PCT/IB2002/004097 patent/WO2003045939A1/en not_active Ceased
- 2002-10-03 RU RU2004116345/04A patent/RU2004116345A/en not_active Application Discontinuation
- 2002-10-03 RS YU44004A patent/RS44004A/en unknown
- 2002-10-03 PL PL02370911A patent/PL370911A1/en unknown
- 2002-10-03 IL IL16097102A patent/IL160971A0/en unknown
- 2002-10-03 AU AU2002337428A patent/AU2002337428A1/en not_active Abandoned
- 2002-10-03 CA CA2462149A patent/CA2462149C/en not_active Expired - Fee Related
- 2002-10-03 CN CNA028208994A patent/CN1639149A/en active Pending
- 2002-10-03 ES ES02772689T patent/ES2295409T3/en not_active Expired - Lifetime
- 2002-10-03 KR KR10-2004-7008290A patent/KR20040054813A/en not_active Ceased
- 2002-10-03 DE DE60223279T patent/DE60223279T2/en not_active Expired - Lifetime
- 2002-10-03 JP JP2003547389A patent/JP4220388B2/en not_active Expired - Fee Related
- 2002-10-03 BR BR0214606-1A patent/BR0214606A/en not_active IP Right Cessation
- 2002-10-03 EP EP02772689A patent/EP1448551B1/en not_active Expired - Lifetime
- 2002-10-03 MX MXPA04005157A patent/MXPA04005157A/en active IP Right Grant
- 2002-10-03 AT AT02772689T patent/ATE377009T1/en not_active IP Right Cessation
- 2002-11-21 DO DO2002000519A patent/DOP2002000519A/en unknown
- 2002-11-22 PY PY200200229003A patent/PY0229003A/en unknown
- 2002-11-25 TW TW091134197A patent/TW200300691A/en unknown
- 2002-11-25 PE PE2002001129A patent/PE20030643A1/en not_active Application Discontinuation
- 2002-11-25 PA PA20028558601A patent/PA8558601A1/en unknown
- 2002-11-27 HN HN2002000334A patent/HN2002000334A/en unknown
- 2002-11-28 AR ARP020104590A patent/AR037591A1/en unknown
- 2002-11-28 GT GT200200245A patent/GT200200245A/en unknown
- 2002-11-29 SV SV2002001419A patent/SV2004001419A/en not_active Application Discontinuation
- 2002-11-29 TN TNTNSN02096A patent/TNSN02096A1/en unknown
- 2002-12-02 US US10/307,603 patent/US20030144506A1/en not_active Abandoned
-
2004
- 2004-03-15 ZA ZA200402054A patent/ZA200402054B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR037591A1 (en) | 2004-11-17 |
| AU2002337428A1 (en) | 2003-06-10 |
| WO2003045939A1 (en) | 2003-06-05 |
| HUP0500117A2 (en) | 2005-05-30 |
| JP2005515986A (en) | 2005-06-02 |
| JP4220388B2 (en) | 2009-02-04 |
| DE60223279D1 (en) | 2007-12-13 |
| BR0214606A (en) | 2004-09-14 |
| DE60223279T2 (en) | 2008-05-29 |
| IL160971A0 (en) | 2004-08-31 |
| RS44004A (en) | 2006-10-27 |
| CN1639149A (en) | 2005-07-13 |
| MXPA04005157A (en) | 2004-08-11 |
| RU2004116345A (en) | 2005-03-27 |
| HUP0500117A3 (en) | 2008-03-28 |
| EP1448551A1 (en) | 2004-08-25 |
| ATE377009T1 (en) | 2007-11-15 |
| EP1448551B1 (en) | 2007-10-31 |
| ES2295409T3 (en) | 2008-04-16 |
| PL370911A1 (en) | 2005-05-30 |
| PA8558601A1 (en) | 2003-06-30 |
| PY0229003A (en) | 2004-06-01 |
| CA2462149C (en) | 2010-06-22 |
| GT200200245A (en) | 2003-09-24 |
| CA2462149A1 (en) | 2003-06-05 |
| TW200300691A (en) | 2003-06-16 |
| SV2004001419A (en) | 2004-02-24 |
| US20030144506A1 (en) | 2003-07-31 |
| PE20030643A1 (en) | 2003-07-23 |
| KR20040054813A (en) | 2004-06-25 |
| HN2002000334A (en) | 2003-02-21 |
| TNSN02096A1 (en) | 2005-12-23 |
| ZA200402054B (en) | 2005-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28135A1 (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| ECSP024393A (en) | SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF NORMAL CELLULAR GROWTH | |
| ECSP055633A (en) | NEW BENZOIMIDAZOLUTILES DERIVATIVES AS ANTIPROLIFERATIVE ANGENTS | |
| PA8487601A1 (en) | USEFUL SUBSTITUTED BICYCLE DERIVATIVES AS AGENTS AGAINST CANCER | |
| AR037517A1 (en) | DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE | |
| PA8490601A1 (en) | QUINOLIN-2-ONA DERIVATIVES SUBSTITUTED WITH HETEROARILO USEFUL AS ANTICANCERIGEN AGENTS. | |
| UY27388A1 (en) | NEW COMPOUNDS | |
| DOP2009000124A (en) | BENZAMIDA DERIVATIVES AS AGONISTA EP4 RECEIVERS | |
| CO4810375A1 (en) | DERIVATIVES OF 9-AMINO-3-KETO Erythromycin | |
| CU23105A3 (en) | NOVEDOUS DERIVATIVES OF AMINODICARBOXILIC ACID WITH PHARMACEUTICAL PROPERTIES | |
| UY29427A1 (en) | SUBSTITUTED DERIVATIVES OF 2,3,4,5- TETRAHIDRO-1H-PIRIDO (4,3-B) INDOL, COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| DOP2002000519A (en) | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| ECSP088829A (en) | BENCIMIDAZOL 5-SULFONAMIDE DERIVATIVES AS CANNABINOID 1 RECEPTOR LIGANDS (CB1) | |
| ATE386725T1 (en) | HETEROCYCLYL COMPOUNDS | |
| UY30397A1 (en) | SUBSTITUTED DERIVATIVES OF THE (3AS, 7AS) -1,3A, 4,5,6,7-HEXAHIDRO-3H-BENZOIMIDAZOL-2-ONA, PREPARATION PROCESS, COMPOSITIONS CONTAINING AND APPLICATIONS | |
| UY28536A1 (en) | DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME. | |
| UY27685A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
| HN2003000162A (en) | DERIVATIVES OF ISOINDOLONE, PREPARATION PROCESS AND INTERMEDIATE COMPOUNDS OF THIS PROCESS, ITS USE AS MEDICATIONS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| UY28357A1 (en) | DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION OF THE SAME AND ITS USES | |
| ECSP024377A (en) | DERIVATIVES OF BENZO (G) QUINOLINA | |
| UY29134A1 (en) | SULFONAMIDS REPLACED BY BENCIMIDAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURE AND APPLICATIONS | |
| UY27557A1 (en) | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH. | |
| PA8474401A1 (en) | 3-KETO TRICYCLIC DERIVATIVES OF 6-0-METHYLERITHROMYCIN | |
| UY26785A1 (en) | SUBSTITUTED BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| SE0400014D0 (en) | Heterocyclic derivatives |